Jie-Kai Cheng

Title: Innovations of Jie-Kai Cheng in Anticancer Research

Introduction

Jie-Kai Cheng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. His innovative work has led to the creation of a patent that addresses critical health challenges.

Latest Patents

Jie-Kai Cheng holds a patent for "Tetrahydrocarboline compounds as anticancer agents." This patent includes tetrahydrocarboline compounds, pharmaceutically acceptable salts, and prodrugs thereof. It also covers compositions that incorporate a pharmaceutically acceptable carrier along with one or more of the tetrahydrocarboline compounds, either alone or in combination with at least one additional therapeutic agent. The methods outlined in the patent focus on using these compounds for the prophylaxis or treatment of proliferative diseases. He has 1 patent to his name.

Career Highlights

Jie-Kai Cheng is currently employed at Novartis Vaccines & Diagnostics GmbH. His role at this prestigious company allows him to work on groundbreaking research that has the potential to impact cancer treatment significantly.

Collaborations

Throughout his career, Jie-Kai Cheng has collaborated with esteemed colleagues, including Weibo Wang and Zhi-Jie Ni. These partnerships have fostered an environment of innovation and shared knowledge in the field of cancer research.

Conclusion

Jie-Kai Cheng's contributions to anticancer research through his innovative patent demonstrate his commitment to advancing medical science. His work at Novartis Vaccines & Diagnostics GmbH and collaborations with other experts further highlight his role in the fight against cancer.